Ketamine is a dissociative anesthetic that is commonly used in surgery and to relieve pain. It is comprised of two molecules, S-Ketamine and R-Ketamine. S-Ketamine, also known as esketamine, is particularly potent and was approved for the treatment of severe and long-term depression in the United States in 2019. The exact mechanism of how ketamine works on the brain is still not fully understood, although it is believed to alter the levels of the neurotransmitter glutamate, thereby affecting mood.
A Brief History of Ketamine
Ketamine was first synthesized in 1964 and later approved by the US Food and Drug Administration as a general anesthetic in 1970. Over the years, researchers have conducted various studies on the effects of ketamine on depression, bipolar disorder, post-traumatic stress disorder, obsessive-compulsive disorder, and more. Despite the positive results obtained from these studies, there is still a lack of comprehensive research on the long-term effects and potential negative side effects of ketamine.
While ketamine is primarily used in specialized clinics and research centers, its clinical use is gradually increasing. The approval of Spravato nasal spray in Australia in 2021 marked a significant step in making ketamine more accessible for the treatment of depression. However, the high cost of the nasal spray, ranging from A$600 to $900 per dose, may limit its accessibility to a wide range of individuals.
Despite the potential benefits of ketamine in treating depression, there are concerns regarding its misuse as a recreational drug. Ketamine has been associated with euphoric and trance-like effects when used recreationally. Additionally, the lack of comprehensive research on the long-term effects raises caution among experts, leading them to recommend careful consideration before prescribing ketamine for depression treatment.
While ketamine shows promise in treating treatment-resistant depression and other mental health conditions, it is essential to approach its use with caution. Seeking medical advice from healthcare professionals is crucial when considering ketamine as a treatment option for depression. Musk’s public discussion of his experiences with mental health challenges may help reduce the stigma surrounding depression and encourage individuals to seek help for mental health conditions.
Leave a Reply